Zoobiotics Ltd

Zoobiotics is focused on wound healing promoted by maggots

ZooBiotic is a spin-out of the Biosurgical Research Unit of the Princess of Wales Hospital, Bridgend. It has raised a total cash amount of £1.75m through equity and loan funding from diverse investors. Initially, the company will stay in the Surgical Materials Testing Laboratory in the Princess of Wales Hospital, Bridgend, until a new facility is completed in the Bridgend area.

Dr. Tim Coombs, CEO
Anthony Phillips
Johanna Bennett

Units 2-4 Dunraven Business Park
Coychurch Road
Bridgend
CF31 3AP
UK
Phone: +44-845-2301810
Fax: 01656-668047

Zoobiotic uses LarvE, maggots of the green bottle fly, which selectively only remove dead or unhealthy tissue. These maggots can effectively treat leg ulcers, wounds associated with diabetes, pressure ulcers, and many other types of infected wounds. Because maggot therapy acts far more quickly than conventional treatments, it also reduces treatment times and associated costs.